Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension.
- DOI
- 10.1183/13993003.01857-2017
- Published
- 2018 Aug
- Container
- The European respiratory journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1183/13993003.01857-2017,
title = {Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension.},
author = {Bellaye PS and Yanagihara T and Granton E and Sato S and Shimbori C and Upagupta C and Imani J and Hambly N and Ask K and Gauldie J and Iglarz M and Kolb M},
year = {2018},
journal = {The European respiratory journal},
doi = {10.1183/13993003.01857-2017},
url = {https://doi.org/10.1183/13993003.01857-2017}
}RIS
TY - JOUR TI - Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension. AU - Bellaye PS AU - Yanagihara T AU - Granton E AU - Sato S AU - Shimbori C AU - Upagupta C AU - Imani J AU - Hambly N AU - Ask K AU - Gauldie J AU - Iglarz M AU - Kolb M PY - 2018 JO - The European respiratory journal DO - 10.1183/13993003.01857-2017 UR - https://doi.org/10.1183/13993003.01857-2017 ER -
APA
PS, B., T, Y., E, G., S, S., C, S., C, U., J, I., N, H., K, A., J, G., M, I., & M, K. (2018). Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension.. The European respiratory journal. https://doi.org/10.1183/13993003.01857-2017
Source records
- pubmed · retrieved 2026-11-10T09:09:08.646Z